Journal Information
Most often read
24021
Recommendations for the reopening and activity resumption of the neurogastroenterology units in the face of the COVID-19 pandemic. Position of the Sociedad Latinoamericana de NeurogastroenterologíaJ.M. Remes-Troche, M.A. Valdovinos-Diaz, R. Viebig, C. Defilippi, L.M. Bustos-Fernández, L. Sole, A.C. Hani-Amador
Rev Gastroenterol Mex. 2020;85:428-36
24021
Open access
20830
Beware: Gastrointestinal symptoms can be a manifestation of COVID-19M. Schmulson, M.F. Dávalos, J. Berumen
Rev Gastroenterol Mex. 2020;85:282-7
20830
Open access
19181
Hepatic manifestations and impact of COVID-19 on the cirrhotic patientJ.A. Velarde-Ruiz Velasco, E.S. García-Jiménez, J.M. Remes-Troche
Rev Gastroenterol Mex. 2020;85:303-11
19181
Open access
19051
Acute diverticulitis of the hepatic flexure mimicking acute cholecystitisM. Gonzalez-Urquijo, A. Baca-Arzaga, G. Lozano-Balderas
Rev Gastroenterol Mex. 2020;85:484-6
19051
Open access
18599
Drug-induced liver injury secondary to anabolic steroid useJ.D. Díaz-García, J. Córdova-Gallardo, A. Torres-Viloria, R. Estrada-Hernández, A. Torre-Delgadillo
Rev Gastroenterol Mex. 2020;85:92-4
18599
Open access
17346
Throat clearing as the only symptom of eosinophilic esophagitis: A case reportN.A. Rojas Pineda, B.M. Morfin Maciel, J. Chanona-Vilchis
Rev Gastroenterol Mex. 2020;85:216-8
17346
Open access
13536
Unexpected better outcome in a liver transplant recipient with COVID-19: a beneficial effect of tacrolimus?I. García-Juárez, A. Campos-Murguía, V.H. Tovar-Méndez, A. Gabutti, I. Ruiz
Rev Gastroenterol Mex. 2020;85:437-42
13536
Open access
12789
Indications for small bowel capsule endoscopy and its safety and diagnostic yield in Mexican patients. Experience at a tertiary care hospital centerG. Blanco-Velasco, C. Mendoza-Segura, O.M. Solórzano-Pineda, O.V. Hernández-Mondragón, V. Paz-Flores, J.M. Blancas-Valencia
Rev Gastroenterol Mex. 2020;85:140-4
12789
Open access
11374
Nonoperative management in a patient with moderate blunt liver traumaA. Pérez-Alonso, P. Rodríguez-Martinón, L. Caballero-Marcos, P. Petrone
Rev Gastroenterol Mex. 2020;85:486-90
11374
Open access
10123
Gastric pneumatosis: The spectrum of the diseaseF.U. Pastor-Sifuentes, P. Moctezuma-Velázquez, J. Aguilar-Frasco
Rev Gastroenterol Mex. 2020;85:219-20
10123
Open access
9772
The Mexican consensus on alcoholic hepatitisJ.A. Velarde-Ruiz Velasco, M.F. Higuera-de la Tijera, G.E. Castro-Narro, F. Zamarripa-Dorsey, J.M. Abdo-Francis, I. Aiza Haddad, J.M. Aldana Ledesma, M.V. Bielsa-Fernández, ... A. Torre-Delgadillo
Rev Gastroenterol Mex. 2020;85:332-53
9772
Open access
9590
Abdominal compartment syndrome: Current concepts and managementE.E. Montalvo-Jave, M. Espejel-Deloiza, J. Chernitzky-Camaño, C.A. Peña-Pérez, E. Rivero-Sigarroa, L.H. Ortega-León
Rev Gastroenterol Mex. 2020;85:443-51
9590
Open access
9536
The Mexican consensus on the diagnosis, treatment, and prevention of NSAID-induced gastropathy and enteropathyM.V. Bielsa-Fernández, J.L. Tamayo-de la Cuesta, J. Lizárraga-López, J.M. Remes-Troche, R. Carmona-Sánchez, J.M. Aldana-Ledesma, J.M. Avendaño-Reyes, M.A. Ballesteros-Amozorrutia, ... F. Zamarripa-Dorsey
Rev Gastroenterol Mex. 2020;85:190-206
9536
Open access
9529
Foramen of Winslow hernia: A rare cause of acute abdomenF.E. Bautista-Álvarez, R.H. Pérez-Soto, U. Clemente-Gutiérrez, A.C. Hernández-Villegas, M. Sierra-Salazar
Rev Gastroenterol Mex. 2020;85:360-2
9529
Open access
9450
Efficacy of rifaximin in the different clinical scenarios of hepatic encephalopathyC.E. Coronel-Castillo, J. Contreras-Carmona, A.C. Frati-Munari, M. Uribe, N. Méndez-Sánchez
Rev Gastroenterol Mex. 2020;85:56-68
9450
Open access
9425
The Mexican consensus on the detection and treatment of early gastric cancerM.E. Icaza-Chávez, M.A. Tanimoto, F.M. Huerta-Iga, J.M. Remes-Troche, R. Carmona-Sánchez, A. Ángeles-Ángeles, F.J. Bosques-Padilla, J.M. Blancas-Valencia, ... A. Zentella-Dehesa
Rev Gastroenterol Mex. 2020;85:69-85
9425
Open access
9212
Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemicG. Miranda-Zazueta, J.A. González-Regueiro, I. García-Juárez, C. Moctezuma-Velázquez, F.J. López-Díaz, B. Pérez-González, L.F. Uscanga-Domínguez, M. Peláez-Luna
Rev Gastroenterol Mex. 2020;85:312-20
9212
Open access
9153
Strongyloides infection mimicking inflammatory bowel diseaseP. Gomez-Hinojosa, C. García-Encinas, A. Carlin-Ronquillo, R.P. Chancafe-Morgan, J. Espinoza-Ríos
Rev Gastroenterol Mex. 2020;85:366-8
9153
Open access
8999
The importance of lactose intolerance in individuals with gastrointestinal symptomsS.E. Martínez Vázquez, J.R. Nogueira de Rojas, J.M. Remes Troche, E. Coss Adame, R. Rivas Ruíz, L.F. Uscanga Domínguez
Rev Gastroenterol Mex. 2020;85:321-31
8999
Open access
8983
Inflammatory bowel disease in Mexico: Epidemiology, burden of disease, and treatment trendsJ.K. Yamamoto-Furusho, F.J. Bosques-Padilla, L. Charúa-Guindic, T. Cortés-Espinosa, R.M. Miranda-Cordero, A. Saez, Y. Ledesma-Osorio
Rev Gastroenterol Mex. 2020;85:246-56
8983
Open access